Resveratrol Prevents Cognitive Impairment in Type 2 Diabetic Mice by Upregulating Nrf2 Expression and Transcriptional Level [Corrigendum]
Wang X, Fang H, Xu G, et al. Diabetes Metab Syndr Obes. 2020;13:1061–1075.The authors have advised the affiliations listed for Hui Fang and the correspondence address on page 1061 are incorrect. The text “Hui Fang2” in the author list should r...
Main Authors: | Wang X, Fang H, Xu G, Yang Y, Xu R, Liu Q, Xue X, Liu J, Wang H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-06-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/corrigendum-resveratrol-prevents-cognitive-impairment-in-type-2-diabet-peer-reviewed-article-DMSO |
Similar Items
-
Resveratrol Prevents Cognitive Impairment in Type 2 Diabetic Mice by Upregulating Nrf2 Expression and Transcriptional Level
by: Wang X, et al.
Published: (2020-04-01) -
Roles of Nrf2 in Gastric Cancer: Targeting for Therapeutic Strategies
by: Tahereh Farkhondeh, et al.
Published: (2021-05-01) -
Roles of CNC Transcription Factors NRF1 and NRF2 in Cancer
by: Hiroki Sekine, et al.
Published: (2021-02-01) -
Flavolignans from Silymarin as Nrf2 Bioactivators and Their Therapeutic Applications
by: Nancy Vargas-Mendoza, et al.
Published: (2020-05-01) -
Soyasaponin Ab protects against oxidative stress in HepG2 cells via Nrf2/HO-1/NQO1 signaling pathways
by: Xiuying Liu, et al.
Published: (2018-06-01)